Related Experiment Video
Updated: Jun 12, 2026
11:17
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Lamotrigine administration in panic disorder with agoraphobia
Vasilios G Masdrakis1, George N Papadimitriou, Panagiotis Oulis
1Eginition Hospital, 1st Department of Psychiatry, Athens University Medical School, Athens, Greece. vmasdrakis@med.uoa.gr
Clinical Neuropharmacology
|May 27, 2010
Summary
Lamotrigine (LTG) shows promise for panic disorder with agoraphobia (PDA). One patient improved significantly with LTG monotherapy, while others saw partial symptom improvement in a 14-week trial.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Panic disorder with agoraphobia (PDA) is a debilitating condition.
- Several anticonvulsants are effective in treating PDA.
- Lamotrigine (LTG) has not been previously studied for PDA treatment.
Observation:
- LTG was administered to 4 outpatients with PDA in a 14-week trial.
- LTG was used as monotherapy in one drug-naive patient with first-onset PDA.
- LTG was used as augmentation therapy in three patients with chronic and severe agoraphobia.
Findings:
- The patient receiving LTG monotherapy showed significant improvement in PDA symptoms.
- Two patients receiving LTG augmentation therapy experienced some degree of symptom improvement.
- LTG demonstrated a positive effect on PDA symptoms in this small cohort.
Implications:
- LTG may be a potential therapeutic option for panic disorder with agoraphobia.
- Further research is warranted to confirm LTG's efficacy and safety in larger PDA populations.
- LTG could offer a novel treatment strategy for patients with PDA, including those with chronic or severe cases.
Related Concept Videos
01:27Panic Disorder
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:30Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:18Anxiety: Overview
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.